Stanisław Szala Selected Research

D-K6L9 peptide

8/2014

D-K6L 9 peptide combination with IL-12 inhibits the recurrence of tumors in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stanisław Szala Research Topics

Disease

26	Neoplasms (Cancer) 01/2021 - 01/2002
21	Melanoma (Melanoma, Malignant) 01/2021 - 09/2002
3	Neoplasm Metastasis (Metastasis) 01/2021 - 09/2002
3	Hypoxia (Hypoxemia) 01/2018 - 01/2006
2	Necrosis 08/2014 - 04/2014
2	Experimental Melanoma 01/2009 - 01/2009
1	Peripheral Arterial Disease 11/2019
1	Cicatrix (Scar) 02/2014
1	Infarction (Infarctions) 02/2014
1	Vascular Tissue Neoplasms 02/2013
1	Hemolysis 06/2010
1	Nasopharyngeal Carcinoma 06/2010
1	Cystic Fibrosis (Mucoviscidosis) 03/2005
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2005
1	Glioblastoma (Glioblastoma Multiforme) 01/2004
1	Carcinoma (Carcinomatosis) 09/2002

Drug/Important Bio-Agent (IBA)

8	Interleukin-12 (IL 12)IBA 01/2021 - 01/2006
5	Peptides (Polypeptides)IBA 08/2014 - 01/2006
5	DNA (Deoxyribonucleic Acid)IBA 06/2010 - 01/2002
4	Pharmaceutical PreparationsIBA 01/2018 - 01/2009
4	Proteins (Proteins, Gene)FDA Link 11/2012 - 09/2002
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2012 - 01/2006
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 01/2009
3	vasostatinIBA 01/2012 - 01/2006
3	Liposomes (Liposome)IBA 06/2010 - 01/2009
2	vadimezanIBA 03/2020 - 01/2018
2	Digoxin (Digitek)FDA LinkGeneric 03/2020 - 01/2018
2	EndoglinIBA 01/2018 - 02/2013
2	CytokinesIBA 04/2014 - 10/2012
2	Recombinant ProteinsIBA 04/2014 - 01/2007
2	SolutionsIBA 02/2014 - 02/2013
2	hydrazine (hydrazine dihydrochloride)IBA 01/2014 - 07/2009
2	ProdrugsIBA 01/2014 - 07/2009
2	HMGB1 Protein (HMG1)IBA 11/2012 - 10/2012
2	Angiogenesis InhibitorsIBA 07/2011 - 09/2002
2	Therapeutic UsesIBA 06/2010 - 01/2006
1	DNA VaccinesIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	VaccinesIBA 12/2015
1	D-K6L9 peptideIBA 08/2014
1	PhosphatidylserinesIBA 08/2014
1	Glycyrrhizic Acid (Glycyrrhizin)IBA 08/2014
1	InterleukinsIBA 04/2014
1	Tyrosine (L-Tyrosine)FDA Link 01/2014
1	Melphalan (Alkeran)FDA LinkGeneric 01/2014
1	Mechlorethamine (Nitrogen Mustard)FDA Link 01/2014
1	AntigensIBA 02/2013
1	Folic Acid (Vitamin M)FDA LinkGeneric 06/2010
1	OligopeptidesIBA 06/2010
1	Antineoplastic Agents (Antineoplastics)IBA 07/2009
1	EnzymesIBA 07/2009
1	Monophenol Monooxygenase (Tyrosinase)IBA 07/2009
1	Levodopa (L Dopa)FDA LinkGeneric 07/2009
1	Carbidopa (Lodosyn)FDA LinkGeneric 07/2009
1	fosbretabulin (combretastatin A4)IBA 01/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2009
1	Protein Isoforms (Isoforms)IBA 01/2009
1	liposomal doxorubicin (Doxil)FDA Link 01/2009
1	Oxygen (Dioxygen)IBA 01/2007
1	Integrin alphaVbeta3IBA 01/2006
1	Melanins (Melanin)IBA 01/2006
1	cobaltous chloride (cobalt(II)chloride)IBA 01/2006
1	ElementsIBA 01/2006
1	AlbuminsIBA 03/2005
1	Angiopoietin-Like Protein 1IBA 01/2005
1	Carcinoembryonic AntigenIBA 01/2004
1	Cytosine DeaminaseIBA 01/2004
1	EndostatinsIBA 09/2002
1	didodecyldimethylammoniumIBA 01/2002
1	3- (N- (N',N'- dimethylaminoethane)carbamoyl)cholesterolIBA 01/2002

Therapy/Procedure

18	Therapeutics 11/2019 - 01/2004
2	Drug Therapy (Chemotherapy) 01/2018 - 01/2006
1	Radiotherapy 01/2018
1	Immunotherapy 02/2013
1	Injections 06/2010
1	Electrodes (Electrode) 09/2002